By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

REGiMMUNE 

3-12-5 Shibaura, Ishizaka
Building 6F
Minato-ku  Tokyo  108-0023  Japan
Phone: 81-3-3456-0820 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
REGiMMUNE To Present Its Method For Long-Term Tolerance In Organ Transplantation At World Transplant Congress In San Francisco 7/28/2014 10:16:32 AM
REGiMMUNE Nabs $9.2 Million Series D Financing 2/14/2014 7:35:05 AM
REGiMMUNE Begins Enrollment For Phase II Clinical Trial For Graft Versus Host Disease 2/6/2014 9:34:01 AM
REGiMMUNE Initiates Phase I/II Clinical Trial for GvHD 2/1/2012 8:40:05 AM
REGiMMUNE Presents New ToleroVax Data at the 2010 American Transplant Congress 5/5/2010 11:19:23 AM
REGiMMUNE to Present Data From Preclinical Study of RGI-2001 at the 2010 American Transplant Congress 4/28/2010 11:26:50 AM
Astellas Pharma Inc. and REGiMMUNE to Collaborate on New Vaccine Technology 7/22/2009 10:34:51 AM
REGiMMUNE Presents Enhanced Efficacy Data in Preclinical Transplantation Models at the 2009 American Transplant Congress 6/1/2009 11:12:47 AM
REGiMMUNE to Present at the 2009 American Transplant Congress 5/12/2009 11:36:38 AM
REGiMMUNE Receives $12 Million in Grants to Develop Transplant and Allergy Drugs 12/8/2008 11:59:24 AM
12
//-->